Testicular Germ Cell Tumor Clinical Trial
Official title:
Accelerated BEP Chemotherapy for Intermediate and High Risk Metastatic Germ Cell Tumor
RATIONALE: Drugs used in chemotherapy, such as bleomycin, etoposide, and cisplatin, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. Colony-stimulating factors, such as pegfilgrastim, may increase the
number of immune cells found in bone marrow or peripheral blood and may help the immune
system recover from the side effects of chemotherapy. Giving combination chemotherapy
together with pegfilgrastim may kill more tumor cells.
PURPOSE: This phase II trial is studying the side effects and how well giving combination
chemotherapy together with pegfilgrastim works in treating men with metastatic germ cell
tumors.
OBJECTIVES:
Primary
- Determine the feasibility of accelerated treatment comprising bleomycin, etoposide,
cisplatin, and pegfilgrastim in men with metastatic germ cell tumors.
- Determine the toxicity of this regimen (particularly with respect to renal, pulmonary,
and neurological function) in these patients.
Secondary
- Determine the response rate in patients treated with this regimen.
- Determine the progression-free survival of patients treated with this regimen.
OUTLINE: This is a non-randomized, pilot study.
Patients receive etoposide IV on days 1-3, cisplatin IV on days 1 and 2, and bleomycin IV
over 2 hours on days 2, 6, and 10. Patients also receive pegfilgrastim subcutaneously on day
4. Treatment repeats every 14 days for up to 4 courses in the absence of disease progression
or unacceptable toxicity.
After completion of study treatment, patients are followed periodically for 2 years.
PROJECTED ACCRUAL: A total of 20 patients will be accrued for this study.
;
Allocation: Non-Randomized, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00788125 -
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT00006126 -
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
|
Phase 1 | |
| Completed |
NCT00003173 -
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors
|
Phase 2 | |
| Completed |
NCT00002596 -
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
|
Phase 3 | |
| Not yet recruiting |
NCT03448822 -
Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour
|
||
| Completed |
NCT01433224 -
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
|
N/A | |
| Recruiting |
NCT01172912 -
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
|
Phase 2 | |
| Completed |
NCT00293384 -
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
|
N/A | |
| Active, not recruiting |
NCT00003643 -
Combination Chemotherapy in Treating Men With Germ Cell Cancer
|
Phase 2/Phase 3 | |
| Completed |
NCT00019331 -
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
|
Phase 2 | |
| Completed |
NCT00003107 -
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
|
Phase 1 | |
| Completed |
NCT00002515 -
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
|
Phase 2 | |
| Recruiting |
NCT06133699 -
Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors
|
N/A | |
| Recruiting |
NCT05670938 -
Follow-up After Surgery for Testicular Cancer
|
||
| Active, not recruiting |
NCT00104676 -
Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
|
Phase 3 | |
| Recruiting |
NCT00551122 -
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT00002508 -
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT00003800 -
Diagnostic Study of Patients With Stage I Testicular Cancer
|
N/A | |
| Terminated |
NCT05012397 -
Milademetan in Advanced/Metastatic Solid Tumors
|
Phase 2 | |
| Completed |
NCT00007813 -
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
|
Phase 1 |